NGL Fine Chem LtdPharmaceuticalsINE887E01022Consolidated₹2777.95+69.40 (+2.56%)Jun-26
Valuation
Market Cap₹1.72K Cr
TTM PE30.00x
Forward PE27.05x
PEG1.57
Book Value₹532.91
P/B5.21x
TTM EPS₹92.59
Fwd EPS₹102.68
TTM Revenue₹536.16 Cr
TTM PAT₹57.21 Cr
TTM EBITDA₹84.18 Cr
TTM EBIT₹63.61 Cr
Last Qtr PAT₹18.40 Cr
Last Qtr EBITDA₹23.29 Cr
Last Qtr EBIT₹18.04 Cr
Profitability
ROE17.38%
ROCE18.32%
TTM NPM10.67%
TTM EBITDA %15.70%
Curr OPM12.55%
Last OPM8.89%
Curr NPM
Last NPM
Curr EPS₹29.78
Last EPS₹21.83
Balance sheet
Equity₹3.09 Cr
Reserve₹326.14 Cr
Total Debt₹108.42 Cr
D/E0.33x
Interest %5.38%
Curr Interest₹0.99 Cr
Price / range
Close₹2777.95
vs 52W High
vs 52W Low
MA50
MA200
Returns
1D+2.56%
1W+4.31%
1M-8.14%
3M-8.72%
6M+26.47%
1Y+104.04%
2Y+31.33%
3Y+39.44%
5Y-2.69%
Diwali+98.42%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1837.30₹4.41L Cr36.4514.50%
DIVISLAB9375.00₹2.49L Cr85.0617.45%
TORNTPHARM4840.00₹1.84L Cr77.3225.70%
ZYDUSLIFE1160.00₹1.16L Cr25.8516.94%
CIPLA1394.50₹1.13L Cr33.419.75%
LAURUSLABS1954.00₹1.06L Cr96.4520.58%
AUROPHARMA1734.00₹99.77K Cr27.099.79%
DRREDDY1185.00₹98.91K Cr30.638.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue136.71+35.5%144.75126.33116.84100.86488.77
Other Income7.362.514.692.416.5514.85
Total Income144.07+34.1%147.26131.02119.25107.41503.63
Interest0.970.991.061.151.214.40
Expenditure-122.32-25.2%-132.38-111.65-108.59-97.70-449.01
PBDT000000
EBITDA19.79+153.1%17.6020.0913.667.8260.46
Depreciation-4.43-4.24-4.35-4.26-3.45-16.30
EBIT15.36+251.5%13.3615.749.404.3744.16
PBT21.75+124.0%14.8819.3710.669.7154.62
Tax-5.29-3.52-4.64-2.76-2.07-12.99
Equity3.093.09003.093.09
OPM15.1010.1015.349.129.0410.85
Net Profit16.45+115.3%11.3514.747.907.6441.63
NPM11.427.7111.666.767.118.27
EPS26.63+115.3%18.3823.8512.7812.3767.39

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue488.77+36.0%359.29+9.2%328.97+19.6%275.05-13.7%318.67+24.9%255.21
Other Income14.859.7615.907.6112.6411.52
Total Income503.63+36.5%369.05+7.0%344.87+22.0%282.67-14.7%331.31+24.2%266.73
Expenditure-449.01-30.1%-345.17-17.3%-294.17-14.9%-256.07+2.4%-262.33-37.5%-190.73
Interest-4.40-2.31-1.34-1.20-1.56-1.84
PBDT000000
EBITDA60.46+135.3%25.70-42.0%44.29+57.7%28.08-57.2%65.57-11.0%73.71
Depreciation-16.30-9.27-8.15-7.90-7.67-7.39
EBIT44.16+168.8%16.43-54.5%36.14+79.1%20.18-65.1%57.90-12.7%66.32
PBT54.62+128.7%23.88-52.9%50.71+90.6%26.60-61.4%68.97-9.3%76
Tax-12.99-5.75-12.19-6.48-16.73-20.53
Equity3.093.090000
OPM (%)10.856.4715.009.0021.0028.00
Net Profit41.63+129.6%18.13-52.9%38.52+91.5%20.12-61.5%52.25-5.8%55.47
NPM (%)8.274.9111.007.0016.0021.00
EPS (Rs)67.39+129.6%29.35-52.9%62.35+91.5%32.56-61.5%84.57-5.8%89.79
CEPS67.3929.3562.3532.5684.5789.79

Consolidated

16 lines · 6 periods
MetricJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue139.16+33.6%149.23127.51120.26104.19500.96
Other Income7.432.464.612.056.3514.73
Total Income146.59+32.6%151.69132.12122.31110.54515.68
Interest0.991.011.081.161.224.47
Expenditure-122.11-23.7%-133.88-111.45-109.35-98.70-452.32
PBDT000000
EBITDA23.29+112.1%21.4122.3217.1610.9872.69
Depreciation-5.25-5.05-5.18-5.09-4.27-19.58
EBIT18.04+168.9%16.3617.1412.076.7153.11
PBT24.48+106.8%17.8120.6712.9611.8463.37
Tax-6.08-4.33-4.98-3.34-2.60-15.24
Equity3.093.09003.093.09
OPM16.7011.7415.6410.6010.7112.29
Net Profit18.40+99.1%13.4915.699.639.2448.13
NPM12.558.8911.887.878.369.33
EPS29.78+99.1%21.8325.4015.5814.9677.90

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue500.95+36.0%368.26+8.7%338.69+21.8%278.08-12.4%317.50+23.1%257.98
Other Income14.738.6314.135.5310.688.02
Total Income515.68+36.8%376.89+6.8%352.82+24.4%283.61-13.6%328.19+23.4%265.99
Expenditure-452.32-29.5%-349.17-17.0%-298.40-16.4%-256.25+2.0%-261.59-38.8%-188.40
Interest-4.47-2.33-1.34-1.20-1.56-1.84
PBDT000000
EBITDA72.68+114.6%33.87-36.4%53.27+55.2%34.32-49.4%67.84-14.9%79.75
Depreciation-19.58-12.45-11.64-11.29-10.37-8.33
EBIT53.10+147.9%21.42-48.5%41.63+80.8%23.03-59.9%57.47-19.5%71.42
PBT63.37+128.7%27.71-49.1%54.42+98.9%27.36-58.9%66.60-14.2%77.59
Tax-15.24-6.59-13.10-6.87-16.70-20.87
Equity3.093.090000
OPM (%)12.297.3515.429.6520.2929.17
Net Profit48.13+127.9%21.12-48.9%41.32+101.6%20.50-58.9%49.90-12.0%56.72
NPM (%)9.335.6011.717.2315.2021.32
EPS (Rs)77.90+127.8%34.19-48.9%66.88+101.6%33.18-58.9%80.77-12.0%91.81
CEPS77.9034.1966.8833.1880.7791.81

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

8
YearTypeAmountEx-Date
2026Final Dividend1.7518 Aug 2026
2025Final Dividend1.7512 Aug 2025
2024Final Dividend1.7516 Aug 2024
2023Final Dividend1.7518 Aug 2023
2022Final Dividend1.7522 Jun 2022
2021Final Dividend1.7512 Aug 2021
2020Final Dividend1.7506 Aug 2020
2019Final Dividend1.7513 Aug 2019

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers